The very real concern about those very long CVS receipts

We can joke about getting a receipt for cough drops that's longer than a small child. But let's talk seriously about what your skin picks up when you handle that ream of thermal paper.

Vox's hilarious story about the ridiculous length of CVS receipts – the height of a small child? the length of a sofa? – failed to mention one of the more pressing concerns about being handed a ream of thermal-sensitive paper upon checkout: Exposure to bisphenol-A, or BPA.


Most receipt paper is imprinted with BPA. When heat is applied, it bonds with a clear dye coating the paper, turning the dye dark (You can see this vividly in the Vox story, where the author ironed a CVS receipt to better measure its length and the receipt turned black). Abundant science shows that the chemical – an endocrine disruptor shown in lab tests to disrupt metabolism, reproductive and immune systems – easily migrates from paper to skin.

A 2012 study estimated that 88 percent of our exposure to BPS, a close cousin to BPA, comes via handling receipts. And scientists have concluded that we all have trace amounts of BPA and/or its cousins, BPS and BPZ, among others, in our bodies.

In January, editor Brian Bienkowski wrote about a study in Michigan that found 93 percent of all paper receipts contained hormane-altering chemicals. And last month Chemical and Engineering News reported that elevated levels of BPA picked up from receipts can linger in the body for a week or more.

Which makes us suggest that there's got to be a better way for CVS to get coupons and alerts into the hands of its customers.

Read the, ahem, lengthy story on CVS's receipts on Vox here.

Print Friendly and PDF
SUBSCRIBE TO EHN'S MUST-READ DAILY NEWSLETTER: ABOVE THE FOLD
Pete Seeger (Credit: Clearwater.org)
Originals

Peter Dykstra: Saviors of the Hudson

On April 1, 1969, a garrulous sportswriter released a book about his true passion. A month later, a smiling folksinger launched a refurbished boat – his true passion.

Keep reading... Show less
Credit: Mike Mozart/flickr
Popular

Up next – Trial in Monsanto’s hometown set for August after $2 billion Roundup cancer verdict

After three stunning courtroom losses in California, the legal battle over the safety of Monsanto's top-selling Roundup herbicide is headed for the company's hometown, where corporate officials can be forced to appear on the witness stand, and legal precedence shows a history of anti-corporate judgments.

Keep reading... Show less
From our Newsroom

Above The Fold

Daily & Weekly newsletters all free.